MARKET

GHRS

GHRS

Gh Research Plc
NASDAQ
15.15
-0.18
-1.17%
After Hours: 15.00 -0.15 -0.99% 16:17 02/11 EST
OPEN
15.40
PREV CLOSE
15.33
HIGH
15.40
LOW
14.50
VOLUME
180.45K
TURNOVER
--
52 WEEK HIGH
19.51
52 WEEK LOW
7.98
MARKET CAP
939.75M
P/E (TTM)
-20.7165
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at GHRS last week (0202-0206)?
Weekly Report · 3d ago
Weekly Report: what happened at GHRS last week (0126-0130)?
Weekly Report · 02/02 09:22
Analysts Offer Insights on Healthcare Companies: GH Research (GHRS) and COMPASS Pathways (CMPS)
TipRanks · 01/30 01:50
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
TipRanks · 01/29 15:30
Analysts Are Bullish on Top Healthcare Stocks: GH Research (GHRS), Viking Therapeutics (VKTX)
TipRanks · 01/28 17:20
Weekly Report: what happened at GHRS last week (0119-0123)?
Weekly Report · 01/26 09:22
GH Research Is Maintained at Outperform by RBC Capital
Dow Jones · 01/23 15:29
GH Research Price Target Raised to $40.00/Share From $33.00 by RBC Capital
Dow Jones · 01/23 15:29
More
About GHRS
GH Research PLC is a clinical-stage biopharmaceutical company. The Company is engaged in offering treatment for psychiatric and neurological disorders. The Company's pipeline includes GH001, GH002 and GH003. The Company focuses on developing its 5- Methoxy-N, N-Dimethyltryptamine, (5-MeO-DMT), therapies for the treatment of patients with Treatment Resistant Depression (TRD). Its product candidate, GH001, is formulated for 5-MeO-DMT administration via an inhalation approach. With GH001, the Company has completed two Phase 1 healthy volunteer clinical trials and a Phase 1/2 clinical trial in patients with treatment-resistant depression (TRD). The GH002 is a 5-MeO-DMT product candidate formulated for administration via an injectable approach. GH002 has completed pre-clinical development to support early clinical trials. The GH003 is a 5-MeO-DMT product candidate formulated for administration via an intranasal administration approach.

Webull offers GH Research PLC stock information, including NASDAQ: GHRS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GHRS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GHRS stock methods without spending real money on the virtual paper trading platform.